Avenue Therapeutics, Inc. - Common Stock (ATXI)
0.4200
0.00 (0.00%)
Avenue Therapeutics Inc is a pharmaceutical company focused on the development of innovative therapies for the treatment of various medical conditions, primarily within the realm of pain management
The company is dedicated to advancing its pipeline of drug candidates, leveraging scientific research and clinical expertise to address unmet needs in healthcare. Avenue Therapeutics aims to bring new options to patients and healthcare providers, with a commitment to improving quality of life through its therapeutic solutions.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · March 18, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 18, 2025
Via Benzinga · March 18, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via Chartmill · March 18, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · March 18, 2025
Via Benzinga · March 18, 2025
Via Benzinga · March 18, 2025
Via Benzinga · March 18, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 17, 2025
Via Benzinga · March 13, 2025

Via Benzinga · January 27, 2025

Via Benzinga · January 24, 2025

Via Benzinga · January 17, 2025

Via Benzinga · December 2, 2024

Via Benzinga · August 26, 2024

ATXI stock results show that Avenue Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 9, 2024

ATXI stock results show that Avenue Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · April 29, 2024

Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warrants for $4.4 million in gross proceeds.
Via Benzinga · April 29, 2024

Via Benzinga · April 26, 2024

Via Benzinga · April 24, 2024

Via Benzinga · April 24, 2024

Avenue Therapeutics shares are trading lower by 28.5% during Wednesday's session. The company is implementing a 1-for-75 reverse stock split.
Via Benzinga · April 24, 2024